These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 22261470)
21. Assessing the contribution of inflammation in models of Alzheimer's disease. Johnston H; Boutin H; Allan SM Biochem Soc Trans; 2011 Aug; 39(4):886-90. PubMed ID: 21787318 [TBL] [Abstract][Full Text] [Related]
22. [Etiology and genetics of Alzheimer disease]. Myhre A; Tysnes OB Tidsskr Nor Laegeforen; 2002 Jan; 122(1):50-3. PubMed ID: 11851296 [TBL] [Abstract][Full Text] [Related]
23. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation. Licastro F; Porcellini E; Caruso C; Lio D; Corder EH Neurobiol Aging; 2007 Nov; 28(11):1637-43. PubMed ID: 16930778 [TBL] [Abstract][Full Text] [Related]
24. The role of the immune system in Alzheimer disease: Etiology and treatment. Jevtic S; Sengar AS; Salter MW; McLaurin J Ageing Res Rev; 2017 Nov; 40():84-94. PubMed ID: 28941639 [TBL] [Abstract][Full Text] [Related]
25. Implication of the immune system in Alzheimer's disease: evidence from genome-wide pathway analysis. Lambert JC; Grenier-Boley B; Chouraki V; Heath S; Zelenika D; Fievet N; Hannequin D; Pasquier F; Hanon O; Brice A; Epelbaum J; Berr C; Dartigues JF; Tzourio C; Campion D; Lathrop M; Amouyel P J Alzheimers Dis; 2010; 20(4):1107-18. PubMed ID: 20413860 [TBL] [Abstract][Full Text] [Related]
27. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease. Cui T; Zhou X; Jin W; Zheng F; Cao X Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232 [TBL] [Abstract][Full Text] [Related]
29. Systemic and acquired immune responses in Alzheimer's disease. Britschgi M; Wyss-Coray T Int Rev Neurobiol; 2007; 82():205-33. PubMed ID: 17678963 [TBL] [Abstract][Full Text] [Related]
30. Innate immunity in Alzheimer's disease: a model for local inflammatory reactions. McGeer EG; McGeer PL Mol Interv; 2001 Apr; 1(1):22-9. PubMed ID: 14993335 [TBL] [Abstract][Full Text] [Related]
32. New therapeutic targeting of Alzheimer's disease with the potential use of proline-rich polypeptide complex to modulate an innate immune response - preliminary study. Sochocka M; Ochnik M; Sobczyński M; Siemieniec I; Orzechowska B; Naporowski P; Leszek J J Neuroinflammation; 2019 Jul; 16(1):137. PubMed ID: 31277647 [TBL] [Abstract][Full Text] [Related]
33. Alzheimer disease: mercury as pathogenetic factor and apolipoprotein E as a moderator. Mutter J; Naumann J; Sadaghiani C; Schneider R; Walach H Neuro Endocrinol Lett; 2004 Oct; 25(5):331-9. PubMed ID: 15580166 [TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease. Lahiri DK; Sambamurti K; Bennett DA Neurobiol Aging; 2004; 25(5):651-60. PubMed ID: 15172744 [TBL] [Abstract][Full Text] [Related]